• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Pain physician

    Pain physician

    JournalISSN 1533-3159eISSN 2150-1149中科院 医学 3区

    年发文量

    研究主题

    论文(3341)

    排序
    1The Effect of Unilateral Subcostal Transversus Abdominis Plane Block Applied As Single or Multiple Injections on Pain in Laparoscopic Cholecystectomy
    Ozden Mesure Gul Nihan, Girgin Dinc Ebru

    Background: Effective postoperative pain management in cases of laparoscopic cholecystectomy is essential for recovery and patient satisfaction. The subcostal transversus abdominis plane (TAP) block is a regional analgesic technique used for upper-abdominal pain. While the single-injection TAP has shown benefits in reducing perioperative opioid consumption, the comparative efficacy of the multi-injection version of this block remains insufficiently studied. Objectives: This study aimed to compare the analgesic efficacy of unilateral single-injection versus multi-injection subcostal TAP blocks in patients undergoing laparoscopic cholecystectomy. Study Design: A prospective, randomized, single-center, parallel-group clinical trial. Setting: Atertiary referral center where patients underwent elective laparoscopic cholecystectomy. Methods: Ninety adult patients (ASA I-III) scheduled for laparoscopic cholecystectomy were randomized into 3 groups: Group S received a single-injection unilateral subcostal TAP block, Group T received a multi-injection unilateral subcostal TAP block, and Group C received no block. Blocks were performed under ultrasound guidance with standardized anesthetic management. The primary endpoint was 24-hour tramadol consumption. Secondary endpoints included postoperative pain scores on the Visual Analog Scale (VAS), intraoperative remifentanil use, postoperative nausea and vomiting (PONV), rescue analgesic requirement, and patient satisfaction. Pain and adverse effects were assessed at 30 minutes and at one, 3, 6, and 24 hours after the procedure. Statistical comparisons were made using analysis of variance (ANOVA), Bonferroni correction, and logistic regression. Results: Eighty-nine patients completed the trial. Both TAP groups demonstrated significantly reduced intraoperative remifentanil consumption compared with controls. At 24 hours, tramadol use was lowest in the multi-injection group, which also showed significantly lower VAS scores at one, 6, and 24 hours than did the single-injection and control groups (P < 0.05). Rescue analgesic requirements were markedly reduced in the multi-injection group, in which PONV incidence was also lowest (92% without PONV vs. 64% in the single-injection group and 52% in the control group; P = 0.007). Patient satisfaction was significantly higher in the multi-injection group, with a greater proportion reporting "very satisfied" (P < 0.001). No major complications were reported. Limitations: The study's single-center design limited external generalizability. Dermatomal mapping of block spread was not performed, and long-term outcomes beyond 24 hours were not evaluated. Conclusions: Both single-and multi-injection subcostal TAP blocks provided effective perioperative analgesia in laparoscopic cholecystectomy. The multi-injection technique demonstrated superior efficacy in pain control, opioid consumption reduction, and patient satisfaction. This type of TAP block may therefore be considered a valuable component of multimodal analgesia protocols for upper-abdominal surgery.

    2026
    引用
    AI阅读
    加入学术空间
    2Translating Evidence to Practice: A Critical and Analytical Summary of the Evidence-Based Guidelines of Facet Joint Interventions in Management of Chronic Spinal Pain
    Laxmaiah Manchikanti,Mahendra R. Sanapati,Alan D. Kaye,Paul J. Christo, Sujeivan Mahendram,Nebojsa Nick Knezevic,Kenneth D. Candido,Annu Navani,Devi E. Nampiaparampil,Amol Soin,Rajesh Naidu Janapala,Joshua A. Hirsch

    Background: Chronic axial spinal pain is a major contributor to disability and healthcare expenditures, with facet joints recognized as one of the established sources of pain. Study Design: Summary and structured synthesis of a comprehensive, multidisciplinary, evidence-based clinical practice guideline developed by systematic review of the literature, Grading of Recommendations Assessment, Development, and Evaluation (GRADE) appraisal, and modified Delphi consensus. Objectives: This article summarizes the recommendations of the 2026 comprehensive evidence-based guidelines for facet joint interventions in the management of chronic spinal pain, published by the American Society of Interventional Pain Physicians (ASIPP). The summary is organized around the recommendations themselves, presenting for each the underlying evidence, the assigned level of evidence, the strength of recommendation, and the practical implications for clinical practice, documentation, and coverage policy. Methods: Literature was searched from 1966 through October 2025. Methodologic quality was assessed using multiple instruments for diagnostic and therapeutic studies. Evidence was graded on a 5-level modified ASIPP scale (Level I, strong, through Level V, consensus-based) supplemented by GRADE certainty ratings, and the strength of each recommendation was rated as strong, moderate, or weak using a scheme adapted from the National Guideline Clearinghouse Extent Adherence to Trustworthy Standards (NEATS) instrument. Institute of Medicine (IOM) standards for trustworthy guidelines were followed. Consensus required at least 80% agreement among eligible panelists without a primary conflict of interest. Results: For non-interventional diagnosis, the level of evidence ranged from I to V, with strong recommendations for structured physical examination and for mandatory fluoroscopic or computed tomography (CT) guidance, and weak recommendations for advanced imaging. For interventional diagnosis, the evidence was Level Ito II in the lumbar spine and Level II in the cervical and thoracic spine, with moderate to strong recommendations for controlled diagnostic medial branch blocks using an 80% pain-relief threshold. For therapeutic interventions, the evidence was Level II with moderate recommendations for cervical and lumbar radiofrequency ablation (RFA) and for therapeutic facet joint nerve blocks in all three spinal regions; Level III with weak to moderate recommendations for thoracic RFA; and Level III to V with weak recommendations for intraarticular injections. For special considerations, evidence ranged from Level II to Level V, addressing repeat interventions, lesion parameters, electrode selection and position, stimulation testing, metallic and electronic implants, antithrombotic therapy, and sedation. Cost-utility analyses demonstrated costs of $4,664 to $5,446 per quality-adjusted life year for lumbar interventions and $4,994 to $5,364 for cervical interventions. Limitations: The recommendations rest on a body of literature that remains heterogeneous, with a paucity of high-quality randomized trials in the thoracic spine, in intraarticular therapy, and in most special-consideration domains. Conclusion: Facet joint interventions provide clinically meaningful and cost-effective benefits to appropriately selected patients with chronic axial spinal pain when diagnosis is established by controlled diagnostic blocks and therapy is delivered under image guidance with defined technical parameters. The 2026 ASIPP recommendations offer a structured, graded framework linking patient selection, procedural technique, safety precautions, and documentation. Further research is needed in the thoracic spine, in intraarticular therapy, and on the comparative effectiveness of therapeutic nerve blocks versus RFA.

    2026
    引用
    AI阅读
    加入学术空间
    3Comparative Outcomes of Posterior and Lateral Sacroiliac Joint Fusions from a Single Academic Pain Center
    Christopher J. Mallard,Michael E. Harned,Jay S. Grider,Preston C. Rippe, Aric Schadler

    Background: Sacroiliac (SI) joint dysfunction is a common source of chronic low back pain. Minimally invasive SI joint fusion techniques, including posterior interpositional and lateral transiliac approaches, have emerged as treatment options for patients who fail conservative management; however, comparative real-world outcome data, particularly from procedures performed by interventional pain physicians, are limited. Objectives: We aimed to evaluate short-term outcomes, complication rates, and revision rates of posterior interpositional vs lateral transiliac SI joint fusion performed by interventional pain physicians at a single academic medical center. Study Design: Retrospective cohort study. Setting: Patients were treated at a pain management clinic within an academic medical center. Methods: A retrospective review was performed of patients' records who underwent SI joint fusion from January 1, 2020 through May 23, 2025. Patients were identified using Current Procedural Terminology codes 27278 and 27279. Demographic data, procedural characteristics, perioperative outcomes, pain scores, and revision surgeries data were collected. Outcomes included preoperative and postoperative month one Visual Analog Scale scores, percentage of pain relief, estimated blood loss, complications, and need for revision surgery. Comparative analyses between posterior and lateral approaches were performed using appropriate statistical tests with statistical significance set at P < 0.05. Results: Eighty patients were included; 33 had posterior interpositional fusion and 47 had lateral transiliac fusion. There were no statistically significant differences in baseline demographics between groups. Both approaches resulted in clinically meaningful short-term pain improvement, with mean Visual Analog Scale scores improving from a preoperative score of 6.6 cm to 3.4 cm at postoperative month one. The posterior interpositional group demonstrated a statistically significant higher revision rate due to loss of efficacy compared with the lateral transiliac group (18.2% vs 0%, P = 0.003). Estimated blood loss and complication rates were low for both approaches. Limitations: Our study is limited by its retrospective design, small sample size, and variable followup duration. Standardized pain scores and percentage pain relief beyond the one-month postoperative visit were not consistently documented and therefore could not be reliably analyzed. Conclusion: Both posterior interpositional and lateral transiliac SI joint fusion performed by interventional pain physicians provided meaningful short-term pain relief in appropriately selected patients. A higher revision rate was observed in the posterior interpositional group, suggesting potential differences in procedural durability. Prospective, adequately powered studies are needed to further define long-term outcomes and optimize procedural selection for managing SI joint-mediated pain.

    2026
    引用
    AI阅读
    加入学术空间
    4Morphometric Analysis of the Corpus Callosum in Relation to Adult Migraine: Association with Disease Duration and Clinical Disability
    Pinar Ozturk, Cile Aktan, Dilek Kilic

    Background: Migraine is increasingly recognized as a disorder associated with widespread neuroanatomical and white-matter alterations rather than a purely episodic pain condition. The corpus callosum, the largest interhemispheric commissural tract, plays a critical role in sensory integration, pain modulation, and interhemispheric connectivity. Structural alterations of the corpus callosum may therefore reflect cumulative neurobiological effects of chronic migraine. Objectives: To compare corpus callosum morphometric characteristics between adult patients with migraine and controls without migraine and to investigate the associations between callosal morphology and clinical disease burden, including migraine duration, age at onset, attack frequency, and migraine-related disability. Study Design: Single-center, cross-sectional observational study. Setting: Tertiary referral neurology center with retrospective magnetic resonance imaging evaluation and prospective clinical assessment. Methods: A total of 101 adult patients diagnosed with migraine according to ICHD-3 criteria and 101 age-and gender-matched controls without migraine were included in our study. Morphometric measurements of the corpus callosum were obtained from midsagittal fluid-attenuated inversion recovery magnetic resonance images using the Witelson segmentation method, assessing genu, truncus, and splenium thickness, as well as anteroposterior length. Group comparisons were performed using the Mann-Whitney U test and the Welch t test, as appropriate. Associations between callosal measurements and clinical variables, including disease duration, age at migraine onset, attack frequency, and Migraine Disability Assessment Scores, were analyzed using the Spearman rank correlation. A receiver operating characteristic analysis was conducted to evaluate the discriminative ability of callosal measurements. Results: Compared with controls, patients with migraine had statistically significant reduced mean (SD) thickness of the genu (10.41 [1.35] mm vs 11.43 [1.08] mm), truncus (5.91 [0.73] mm vs 6.68 [0.84] mm), and splenium (10.73 [1.16] mm vs 11.13 [1.16] mm) all P < 0.05; anteroposterior length did not differ significantly. Within the migraine group, genu thickness correlated positively with age at onset (rho = 0.33) and Migraine Disability Assessment Score (rho = 0.37) and negatively with disease duration (rho =-0.30). Attack frequency showed no significant association with any morphometric parameter. A receiver operating characteristic analysis showed a modest discriminatory performance for genu and truncus thickness. Limitations: Our study's cross-sectional design precludes causal inference. Also, morphometric measurements were limited to a 2-dimensional assessment thereby making us unable to conduct diffusion or volumetric analyses. Conclusions: Adult migraine is associated with segmental thinning of the corpus callosum, particularly in the genu and splenium. The relationships with age at onset and disease duration support the concept of cumulative, long-term interhemispheric remodeling in migraine, rather than short-term attack-related effects.

    2026
    引用
    AI阅读
    加入学术空间
    5Local Coverage Determinations for Peripheral Nerve Injections and Procedures for Chronic Pain: Policy Changes, Clinical Limitations, and Health-Equity Implications
    Amol Soin,Mahendra R. Sanapati,Annu Navani,Laxmaiah Manchikanti

    Five Medicare Administrative Contractors (MACs)-CGS, Palmetto GBA, Wellpoint Federal (formerly National Government Services), Wisconsin Physicians Service, and Noridian-participated a collaborative policy-development process addressing peripheral nerve injections and related procedures for chronic pain. Novitas Solutions and First Coast Service Options did not participate. The September 2025 draft policies would have limited coverage principally to radiofrequency neurolysis for trigeminal neuralgia and corticosteroid injections for carpal tunnel syndrome and Morton neuroma, with lifetime caps on the latter procedures. After public comment and further evidence review, four contractors published materially identical final LCDs, with a notice period from September 10 through October 24, 2026, and an effective date of October 25, 2026. The final policies restored limited, criteria-based coverage for sympathetic blocks in complex regional pain syndrome, genicular nerve blocks and ablation for selected patients with knee osteoarthritis, greater occipital nerve blocks for occipital neuralgia, and selected suprascapular nerve blocks. They also removed the lifetime caps on median-nerve and Morton-neuroma injections. Pudendal, intercostal, ganglion impar, ulnar, and unspecified other peripheral-nerve procedures remain noncovered when performed for chronic pain. This health-policy analysis compares the draft and final policies, distinguishes Noridian's participation in the collaborative process from publication of final LCD, summarizes coding and documentation requirements, and examines the access and health-equity implications of geographically discordant Medicare coverage.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3341 篇论文

    高被引作者

    作者引用发文
    Laxmaiah Manchikanti28754374
    Ramsin Benyamin1240099
    Pampati Vidyasagar11358144
    Joshua Hirsch11230186
    Vijay Singh11121107
    Sukdeb Datta973347
    Falco Frank J E733285
    Mark V. Boswell698168
    Bert Fellows672851
    Standiford Helm652058

    高产作者

    作者引用发文
    Laxmaiah Manchikanti28754374
    Joshua Hirsch11230186
    Pampati Vidyasagar11358144
    Alan D. Kaye4332142
    Vijay Singh11121107
    Ramsin Benyamin1240099
    Falco Frank J E733285
    Mark V. Boswell698168
    Mahendra R Sanapati103463
    Amol Soin143259

    相关期刊

    Current Pain and Headache Reports
    The Korean journal of pain
    Journal of pain research
    Pain management
    Pain and therapy
    Regional Anesthesia and Pain Medicine
    Pain Practice
    Pain Medicine
    Global Spine Journal
    Spine